Journal of Vaccine Research 2024, Vol.14, No.3, 107-119 http://medscipublisher.com/index.php/jvr 119 Tall H., Adam P., Tiendrebeogo A., Vincent J., Schaeffer L., Platen C., Fernandes-Pellerin S., Sawadogo F., Bokoum A., Bouda G., Ouattara S., Ouédraogo I., Herrant M., Boucheron P., Sawadogo A., Betsem E., Essoh A., Kaboré L., Ouattara A., Meda N., Hien H., Gosset A., Giles-Vernick T., Boyer S., Kania D., Vray M., and Shimakawa Y., 2021, Impact of Introducing hepatitis B birth dose vaccines into the infant immunization program in burkina faso: study protocol for a stepped wedge cluster randomized Trial (NéoVac Study), Vaccines, 9(6): 583. https://doi.org/10.3390/vaccines9060583 Te H., and Jensen D., 2010, Epidemiology of hepatitis B and C viruses: a global overview, Clinics in Liver Disease, 14(1): 1-21. https://doi.org/10.1016/j.cld.2009.11.009. Tian Y., Hua W., Wu Y., Zhang T., Wang W., Wu H., Guo C., and Huang X., 2021, Immune response to hepatitis B virus vaccine among people living with HIV: a meta-analysis, Frontiers in Immunology, 12: 745541. https://doi.org/10.3389/fimmu.2021.745541 Woo P., Wong L., Zheng B., and Yuen K., 2001, Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium, Vaccine, 19(20-22): 2945-2954. https://doi.org/10.1016/S0264-410X(00)00530-2 Yang S., Tian G., Cui Y., Ding C., Deng M., Yu C., Xu K., Ren J., Yao J., Li Y., Cao Q., Chen P., Xie T., Wang C., Wang B., Mao C., Ruan B., Jiang T., and Li L., 2016, Factors influencing immunologic response to hepatitis B vaccine in adults, Scientific Reports, 6(1): 27251. https://doi.org/10.1038/srep27251 Yao T., Shao Z., Wu L., Dong S., Gao L., Wu Y., Shi X., Shi J., Liu G., Wang J., Zhao H., Guo H., Liu H., Wu X., Liu L., Song X., Zhu J., Zhang Y., Feng Y., Liang X., and Wang S., 2021, Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: a 3-year follow-up study in China, Vaccine, 39(18): 2537-2544. https://doi.org/10.1016/j.vaccine.2021.03.074 Yap I., Guan R., and Chan S., 1992, Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein-a preliminary study on immunogenicity, Vaccine, 10(7): 439-442. https://doi.org/10.1016/0264-410X(92)90391-V Yerushalmi B., Raz R., Blondheim O., Shumov E., Koren R., and Dagan R., 1997, Safety and immunogenicity of a novel mammalian cell-derived recombinant hepatitis B vaccine containing Pre-S1 and Pre-S2 antigens in neonates, The Pediatric Infectious Disease Journal, 16(6): 587-592. .https://doi.org/10.1097/00006454-199706000-00009. PMid:9194109 Zanetti A., Damme P., and Shouval D., 2008, The global impact of vaccination against hepatitis B: a historical overview, Vaccine, 26(49): 6266-6273. https://doi.org/10.1016/j.vaccine.2008.09.056. Zhang Z., Liang Z., Zeng J., Zhang J., He P., Su J., Zeng Y., Fan R., Zhao D., Ma W., Zeng G., Zhang Q., and Zheng H., 2019, Immunogenicity and safety of an inactivated enterovirus 71 vaccine administered simultaneously with recombinant hepatitis B vaccine and group A meningococcal polysaccharide vaccine: a phase IV, open-label, single-center, randomized, non-inferiority trial, The Journal of Infectious Diseases, 220(3): 392-399. https://doi.org/10.1093/infdis/jiz129. Zhao H., Zhou X., and Zhou Y., 2020, Hepatitis B vaccine development and implementation, Human Vaccines and Immunotherapeutics, 16: 1533-1544. https://doi.org/10.1080/21645515.2020.1732166 Zhou Q., Wang F., Yang F., Wang Y., Zhang X., and Sun S., 2010, Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant, Vaccine, 28(5): 1357-1362. https://doi.org/10.1016/j.vaccine.2009.11.006 PMid:19932674
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==